281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

Year: 2021

VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date

October 4, 2021

Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones have been reached for its new headquarters and expanded manufacturing facility in Conroe, TX. The Woodlands, TX – VGXI, Inc., an industry leading contract developer and manufacturer (CDMO) for nucleic acid biopharmaceuticals including DNA vaccines and gene therapies, announced that its new headquarters and manufacturing… Read More »

Filed Under: News

VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU

August 10, 2021

Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in support of a gene therapy for the rare genetic disease, Aspartylglucosaminuria (AGU). The Woodlands, TX – Contract developer and manufacturer VGXI, Inc., which specializes in production of nucleic acid-based biopharmaceuticals for DNA vaccines and gene therapy applications, announced it has been… Read More »

Filed Under: General, News

VGXI Celebrates Topping Out for New Headquarters and Manufacturing Facility in Conroe, TX

April 20, 2021

Texas-based plasmid DNA Manufacturer VGXI, Inc. Celebrates the Topping Out for its New Headquarters and Expanded Manufacturing Facility. The Woodlands, TX – VGXI, Inc., a highly specialized contract developer and manufacturer for DNA-based biopharmaceuticals, celebrated a significant milestone for its new headquarters and manufacturing facility with a topping out ceremony on Monday, April 19, 2021…. Read More »

Filed Under: Events, News

VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies

March 16, 2021

Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced hepatocellular carcinoma (HCC). The Woodlands, TX – VGXI, Inc., an industry leading manufacturer for pre-clinical through cGMP clinical plasmid DNA, announced that its partner Geneos Therapeutics, Inc…. Read More »

Filed Under: General, News

VGXI Official Update Following Winter Storm Uri

February 23, 2021

To our Valued Clients and Business Partners, Thank you for everyone’s concern regarding the severe winter storm conditions that swept through Texas during the week of 15Feb21. The VGXI offices remained closed for the week to ensure the safety of all our team members as they faced challenges from icy road conditions, power outages, and… Read More »

Filed Under: General, News

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy